These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23631591)

  • 21. A quantum chemical study of the mechanism of action of Vitamin K epoxide reductase (VKOR) II. Transition states.
    Davis CH; Deerfield D; Wymore T; Stafford DW; Pedersen LG
    J Mol Graph Model; 2007 Sep; 26(2):401-8. PubMed ID: 17182266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The membrane topology of vitamin K epoxide reductase is conserved between human isoforms and the bacterial enzyme.
    Cao Z; van Lith M; Mitchell LJ; Pringle MA; Inaba K; Bulleid NJ
    Biochem J; 2016 Apr; 473(7):851-8. PubMed ID: 26772871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism.
    Timson DJ
    Curr Drug Targets; 2017; 18(5):500-510. PubMed ID: 26201483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.
    Rishavy MA; Usubalieva A; Hallgren KW; Berkner KL
    J Biol Chem; 2011 Mar; 286(9):7267-78. PubMed ID: 20978134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin and vitamin K compete for binding to Phe55 in human VKOR.
    Czogalla KJ; Biswas A; Höning K; Hornung V; Liphardt K; Watzka M; Oldenburg J
    Nat Struct Mol Biol; 2017 Jan; 24(1):77-85. PubMed ID: 27941861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ; Hildebrandt EF; Suttie JW
    J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conversion of vitamin K epoxide to vitamin K quinone and vitamin K quinone to vitamin K hydroquinone uses the same active site cysteines.
    Jin DY; Tie JK; Stafford DW
    Biochemistry; 2007 Jun; 46(24):7279-83. PubMed ID: 17523679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of a bacterial homologue of vitamin K epoxide reductase.
    Li W; Schulman S; Dutton RJ; Boyd D; Beckwith J; Rapoport TA
    Nature; 2010 Jan; 463(7280):507-12. PubMed ID: 20110994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin K epoxide reductase prefers ER membrane-anchored thioredoxin-like redox partners.
    Schulman S; Wang B; Li W; Rapoport TA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15027-32. PubMed ID: 20696932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
    Wallin R; Wajih N; Hutson SM
    Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu.
    Chen X; Jin DY; Stafford DW; Tie JK
    Blood; 2018 Nov; 132(18):1974-1984. PubMed ID: 30089628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VKORC1 and the vitamin K cycle.
    Garcia AA; Reitsma PH
    Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the gene for vitamin K epoxide reductase.
    Li T; Chang CY; Jin DY; Lin PJ; Khvorova A; Stafford DW
    Nature; 2004 Feb; 427(6974):541-4. PubMed ID: 14765195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phylogeny of the Vitamin K 2,3-Epoxide Reductase (VKOR) Family and Evolutionary Relationship to the Disulfide Bond Formation Protein B (DsbB) Family.
    Bevans CG; Krettler C; Reinhart C; Watzka M; Oldenburg J
    Nutrients; 2015 Jul; 7(8):6224-49. PubMed ID: 26230708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
    Wajih N; Hutson SM; Wallin R
    J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system.
    Wajih N; Sane DC; Hutson SM; Wallin R
    J Biol Chem; 2005 Mar; 280(11):10540-7. PubMed ID: 15640149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.
    Caspers M; Czogalla KJ; Liphardt K; Müller J; Westhofen P; Watzka M; Oldenburg J
    Thromb Res; 2015 May; 135(5):977-83. PubMed ID: 25747820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural features determining the vitamin K epoxide reduction activity in the VKOR family of membrane oxidoreductases.
    Shen G; Li C; Cao Q; Megta AK; Li S; Gao M; Liu H; Shen Y; Chen Y; Yu H; Li S; Li W
    FEBS J; 2022 Aug; 289(15):4564-4579. PubMed ID: 35113495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin K epoxide reductase expression and prostate cancer risk.
    Tew BY; Pal SK; He M; Tong T; Wu H; Hsu J; Liu X; Neuhausen SL; Jones JO
    Urol Oncol; 2017 Mar; 35(3):112.e13-112.e18. PubMed ID: 27889279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and cellular basis of vitamin K antagonism.
    Liu S; Shen G; Li W
    J Thromb Haemost; 2022 Sep; 20(9):1971-1983. PubMed ID: 35748323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.